Literature DB >> 26900132

Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old.

Ron Brookmeyer1, Claudia H Kawas2, Nada Abdallah3, Annlia Paganini-Hill4, Ronald C Kim5, María M Corrada6.   

Abstract

INTRODUCTION: The number of persons aged >90 years will grow significantly in coming decades. This group has the highest rates of dementia, most commonly Alzheimer's disease (AD).
METHODS: Using The 90+ Study, we developed a statistical model for dementia risk based on brain pathologies. Intervention scenarios which reduce or eliminate AD pathology were considered, and the numbers of dementia cases among the U.S. oldest-old that could be prevented were estimated.
RESULTS: The U.S. dementia prevalence among the oldest-old will increase from 1.35 million in 2015 to 4.72 million in 2050. If interventions eliminate AD pathology, dementia prevalence would be reduced by approximately 50%, averting nearly 2.4 million cases in 2050. However, large numbers of dementia cases would still remain. DISCUSSION: Reducing AD pathology would significantly decrease the public health burden of dementia. However, other interventions are needed to address the burden associated with other dementing pathologies prevalent in the oldest-old.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia; Intervention; Oldest-old; Pathology; Prediction; Prevalence; Prevention

Mesh:

Year:  2016        PMID: 26900132      PMCID: PMC4808364          DOI: 10.1016/j.jalz.2016.01.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  31 in total

1.  The estimation and interpretation of attributable risk in health research.

Authors:  S D Walter
Journal:  Biometrics       Date:  1976-12       Impact factor: 2.571

2.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

3.  Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.

Authors:  Lon White; Brent J Small; Helen Petrovitch; G Webster Ross; Kamal Masaki; Robert D Abbott; John Hardman; Daron Davis; James Nelson; William Markesbery
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

4.  Pathological correlates of dementia in a longitudinal, population-based sample of aging.

Authors:  Joshua A Sonnen; Eric B Larson; Paul K Crane; Sebastien Haneuse; Ge Li; Gerald D Schellenberg; Suzanne Craft; James B Leverenz; Thomas J Montine
Journal:  Ann Neurol       Date:  2007-10       Impact factor: 10.422

Review 5.  Biostatistics and epidemiology: measuring the risk attributable to an environmental or genetic factor.

Authors:  Jacques Benichou
Journal:  C R Biol       Date:  2007-04-12       Impact factor: 1.583

6.  Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

Authors:  B T Hyman; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

Review 7.  Sources of variability in prevalence rates of Alzheimer's disease.

Authors:  M Corrada; R Brookmeyer; C Kawas
Journal:  Int J Epidemiol       Date:  1995-10       Impact factor: 7.196

8.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

9.  Prevalence of dementia in the United States: the aging, demographics, and memory study.

Authors:  B L Plassman; K M Langa; G G Fisher; S G Heeringa; D R Weir; M B Ofstedal; J R Burke; M D Hurd; G G Potter; W L Rodgers; D C Steffens; R J Willis; R B Wallace
Journal:  Neuroepidemiology       Date:  2007-10-29       Impact factor: 3.282

Review 10.  The oldest old and the 90+ Study.

Authors:  Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

View more
  18 in total

1.  Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.

Authors:  Hiroko H Dodge; Jian Zhu; Randy Woltjer; Peter T Nelson; David A Bennett; Nigel J Cairns; David W Fardo; Jeffrey A Kaye; Deniz-Erten Lyons; Nora Mattek; Julie A Schneider; Lisa C Silbert; Chengjie Xiong; Lei Yu; Frederick A Schmitt; Richard J Kryscio; Erin L Abner
Journal:  Alzheimers Dement       Date:  2016-12-23       Impact factor: 21.566

2.  Angelica polysaccharide ameliorates memory impairment in Alzheimer's disease rat through activating BDNF/TrkB/CREB pathway.

Authors:  Qian Du; Xiaoyu Zhu; Jieru Si
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-17

3.  Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.

Authors:  Chunyan Zhu; Bing Xu; Xiaohong Sun; Qiwen Zhu; Yi Sui
Journal:  Mol Neurobiol       Date:  2016-11-23       Impact factor: 5.590

4.  Trajectory and variability characterization of the Montreal cognitive assessment in older adults.

Authors:  Michael Malek-Ahmadi; Kathy O'Connor; Sharon Schofield; David W Coon; Edward Zamrini
Journal:  Aging Clin Exp Res       Date:  2017-11-29       Impact factor: 3.636

Review 5.  Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.

Authors:  Dana P Goldman; Howard Fillit; Peter Neumann
Journal:  Alzheimers Dement       Date:  2018-04-18       Impact factor: 21.566

6.  Is use of the internet in midlife associated with lower dementia incidence? Results from the English Longitudinal Study of Ageing.

Authors:  Eleonora d'Orsi; Andre Junqueira Xavier; Snorri Bjorn Rafnsson; Andrew Steptoe; Eef Hogervorst; Martin Orrell
Journal:  Aging Ment Health       Date:  2017-08-10       Impact factor: 3.658

7.  Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias.

Authors:  Lei Yu; Patricia A Boyle; Aliza P Wingo; Jingyun Yang; Tianhao Wang; Aron S Buchman; Thomas S Wingo; Nicholas T Seyfried; Allan I Levey; Philip L De Jager; Julie A Schneider; David A Bennett
Journal:  Neurology       Date:  2021-12-22       Impact factor: 9.910

8.  Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest-Old.

Authors:  Thomas J Montine; Maria M Corrada; Claudia Kawas; Syed Bukhari; Lon White; Lu Tian; Brenna Cholerton
Journal:  Neurology       Date:  2022-06-15       Impact factor: 11.800

9.  Reducing Your Risk of Alzheimer's Dementia: Building a Better Brain as We Age.

Authors:  David A Bennett
Journal:  Arch Clin Neuropsychol       Date:  2021-10-13       Impact factor: 3.448

10.  Neighborhoods, sleep quality, and cognitive decline: Does where you live and how well you sleep matter?

Authors:  Jaimie C Hunter; Elizabeth P Handing; Ramon Casanova; Maragatha Kuchibhatla; Michael W Lutz; Santiago Saldana; Brenda L Plassman; Kathleen M Hayden
Journal:  Alzheimers Dement       Date:  2018-02-01       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.